Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
30.00
-0.05 (-0.17%)
Sep 26, 2025, 2:40 PM CST
TPEX:6704 Revenue
Gwo Xi Stem Cell Applied Technology Co. , had revenue of 94.49M TWD in the half year ending June 30, 2025, with 34.44% growth. This brings the company's revenue in the last twelve months to 184.91M, up 22.87% year-over-year. In the year 2024, Gwo Xi Stem Cell Applied Technology Co. , had annual revenue of 170.03M with 20.44% growth.
Revenue (ttm)
184.91M
Revenue Growth
+22.87%
P/S Ratio
15.57
Revenue / Employee
n/a
Employees
34
Market Cap
2.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 170.03M | 28.85M | 20.44% |
Dec 31, 2023 | 141.18M | -39.49M | -21.86% |
Dec 31, 2022 | 180.67M | -62.09M | -25.58% |
Dec 31, 2021 | 242.75M | 54.21M | 28.75% |
Dec 31, 2020 | 188.54M | 11.86M | 6.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 44.83M |
PharmaEssentia | 12.63B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Lumosa Therapeutics | 37.25M |
Oneness Biotech | 112.57M |
Polaris Group | 64.02M |
Center Laboratories | 1.60B |